Authors : Ashwani Kumar; Zehra Husaini; Khyati Lehari; Ritika Yadav; Supriya Tomar

Volume/Issue : Volume 8 - 2023, Issue 12 - December

Google Scholar : http://tinyurl.com/3vsu9622

Scribd : http://tinyurl.com/5n9x6rfm

DOI : https://doi.org/10.5281/zenodo.10461455

Abstract : The Cannabaceae family includes Cannabis sativa. Carl Linneus made the initial discovery of the species in 1753. Native to Eastern Asia, Cannabis sativa is an annual herbaceous flowering plant that is now widely cultivated and distributed throughout the world. Its phytochemical byproducts, hashish and marijuana, are the most produced and commonly used illegal drugs in Europe and India, where they are also deeply ingrained in Indian culture and religious customs. Although this plant is most well-known for its narcotic qualities, pre-clinical research on hemp derivatives revealed potential anti-oxidative, anti-hypertensive, anti- inflammatory, anti-diabetic, anti-neuroinflammatory, anti-arthritic, anti-acne, and anti-microbial effects. This research presents a comprehensive overview of its phytoconstituents, antioxidants, antimicrobials, and therapeutic features. Considering the numerous significant new discoveries concerning this plant. This plant produces a broad variety of secondary metabolites that have been identified and show an extensive spectrum of biological activity. Cannabidiol (CBD) and delta-9 tetrahydrocannabinol (delta9-THC) are the main components of cannabis that give it its pharmacological effects. To sum up, Cannabis sativa is a researched plant with potential medical uses. With an eye toward the sociolegal context and potential directions for future research, this attempts to bring up to date the existing knowledge and data regarding the use of cannabis and its derivatives.

Keywords : Cannabis Sativa, Indian Hemp, Phytochemical, Saintly Herb, Marijuana.